Innovations for Next-Generation Antibody-Drug Conjugates
Antibody-drug conjugates (ADCs) stand at the verge of a transformation. Scores of clinical programs have yielded only a few regulatory approvals, but a wave of technological innovation now empowers us to overcome past technical challenges. This volume focuses on the next generation of ADCs and the i...
Συγγραφή απο Οργανισμό/Αρχή: | SpringerLink (Online service) |
---|---|
Άλλοι συγγραφείς: | Damelin, Marc (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt) |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Humana,
2018.
|
Έκδοση: | 1st ed. 2018. |
Σειρά: | Cancer Drug Discovery and Development,
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Παρόμοια τεκμήρια
-
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas
Έκδοση: (2018) -
Targeted Therapies for Lung Cancer
Έκδοση: (2019) -
Current Applications for Overcoming Resistance to Targeted Therapies
Έκδοση: (2019) -
Estrogen Receptor and Breast Cancer Celebrating the 60th Anniversary of the Discovery of ER /
Έκδοση: (2019) -
Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs Cell Signaling Pathways and microRNAs in Cancer Biology /
Έκδοση: (2018)